New mixed-ligand Zn()-based MOF as a nanocarrier platform for improved antibacterial activity of clinically approved drug levofloxacin
The advancement of metal-organic frameworks (MOFs) operating as drug delivery systems is of extensive interest as their controlled drug release and specific delivery are very propitious. Herein, we report a new metal-organic framework (Zn-nMOF) formulated from a mixed ligand system comprising 5-hydr...
Gespeichert in:
Veröffentlicht in: | New journal of chemistry 2023-04, Vol.47 (15), p.7416-7424 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The advancement of metal-organic frameworks (MOFs) operating as drug delivery systems is of extensive interest as their controlled drug release and specific delivery are very propitious. Herein, we report a new metal-organic framework (Zn-nMOF) formulated from a mixed ligand system comprising 5-hydroxyisophthalate ions (
L
1
) and 5,5′-dimethyl-2,2′-bipyridine (
L
2
) with zinc ions serving as metal centers. The crystal structure of the synthesized MOF was determined by single-crystal X-ray analysis and further supported by FTIR, PXRD, TEM, SEM, EDX, and UV/visible spectroscopy. The loading of a clinically approved broad-spectrum drug levofloxacin onto this zinc-based MOF was achieved by activating the pendent hydroxyl groups of the organic linker (5-hydroxyisophthalic acid) onto the surface of the MOF using the activator 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC). The confirmation of successful conjugation of levofloxacin onto the MOF and formation of Levo@Zn-nMOF was well supported by FTIR, UV/visible, SEM, and EDX techniques. The levofloxacin-conjugated Zn-nMOF (Levo@Zn-nMOF) showed increased antibacterial efficacy compared to pure levofloxacin against Gram-positive and Gram-negative bacteria, specifically
S. aureus
(MIC-64.4 μg mL
−1
),
B. subtilis
(MIC-94.97 μg mL
−1
),
E. coli
(MIC-26.0 μg mL
−1
), and
P. aeruginosa
(MIC-67.48 μg mL
−1
). The efficiency of conjugated levofloxacin showed improvement by 1.65 times, 1.71 times, 1.56 times, and 1.03 times in
S. aureus
,
B. subtilis
,
E. coli
, and
P. aeruginosa
, respectively. This work shows that a significant increase in antibacterial efficacy can be achieved for certain antibiotics by conjugating them to the MOF surface through a covalent bond linkage.
The advancement of metal-organic frameworks (MOFs) operating as drug delivery systems is of extensive interest as their controlled drug release and specific delivery are very propitious. |
---|---|
ISSN: | 1144-0546 1369-9261 |
DOI: | 10.1039/d3nj00114h |